Cure My Disease

Don't miss your cure!

 Log in / Sign up

First human tests begin for promising new autoimmune disease drug

NCT ID NCT06647069

Recruiting now Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing a new drug called SAR448501 in adults with moderate-to-severe lupus or rheumatoid arthritis who haven't gotten enough relief from their current treatments. The main goal is to find safe dose levels and see how the drug behaves in the body. About 62 participants will receive the drug and be closely monitored for side effects and early signs of benefit over approximately 13 months.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SJOGREN'S SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Investigational Site Number : 001-201

    RECRUITING

    Melbourne, Victoria, 3004, Australia

  • Investigational Site Number : 001-203

    RECRUITING

    Brisbane, Queensland, 4151, Australia

  • Investigational Site Number : 001-301

    RECRUITING

    Auckland, 0622, New Zealand

  • Investigational Site Number : 001-401

    RECRUITING

    Sarajevo, 71000, Bosnia and Herzegovina

  • Investigational Site Number : 001-402

    RECRUITING

    Mostar, 88000, Bosnia and Herzegovina

  • Investigational Site Number : 001-801

    RECRUITING

    Pretoria, 0002, South Africa

  • Investigational Site Number : 001-803

    RECRUITING

    Pretoria, 0184, South Africa

  • Investigational Site Number : 001-804

    RECRUITING

    Vereeniging, 1935, South Africa

Conditions

Explore the condition pages connected to this study.

CLE CUTANEOUS LUPUS DCSSC DERMATOMYOSITIS DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS POLYMYOSITIS PRIMARY SJÖGREN SYNDROME RHEUMATOID ARTHRITIS (RA) SCLERODERMA SJOGREN'S SYNDROME SLE SLE (SYSTEMIC LUPUS) SSC, DIFFUSE SCLEROSIS SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)